Grace Therapeutics, Inc.
GRCE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001444192
In the last 90 days, Grace Therapeutics, Inc. insiders filed 11 open-market purchases and 0 sales; 33 institutions reported holding it in 13F filings for Q2 2026, worth $8.74M in total; no superinvestor holds it.
Holders of 5% or more of GRCE
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Grace Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 13G | 13.07%2.75M shares | New | Aug 7, 20261 filing | Aug 7, 2026 | SEC |
| ADAR1 Capital Management, LLC | 13G/A | 9.90%1.81M shares | 0.00 ppfrom 9.90% | Jul 10, 20247 filings | Aug 14, 2026 | SEC |
| Nantahala Capital Management, LLC | 13G/A | 6.75%1.18M shares | −3.24 ppfrom 9.99% | May 15, 20254 filings | Aug 14, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
19 Schedule 13D and 13G filings on Grace Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20265:03 PM ET | ADAR1 Capital Management, LLCand 2 others | 13G/A | 9.90%1.81M shares | 0.00 ppfrom 9.90% | Jun 30, 2026 | SEC |
| Aug 14, 20264:44 PM ET | Nantahala Capital Management, LLCand 2 others | 13G/A | 6.75%1.18M shares | −3.24 ppfrom 9.99% | Jun 30, 2026 | SEC |
| Aug 7, 20264:05 PM ET | Opaleye Management Inc.and 2 others | 13G | 13.07%2.75M shares | New | Aug 5, 2026 | SEC |
| May 15, 20268:06 PM ET | ADAR1 Capital Management, LLCand 2 others | 13G/A | 9.90%1.72M shares | 0.00 ppfrom 9.90% | Mar 31, 2026 | SEC |
| Apr 27, 20268:07 AM ET | Hirschman Orinand 1 other | 13G/A | 4.90%814.0K shares | −1.00 ppfrom 5.90%Below 5% | Mar 31, 2026 | SEC |
| Feb 17, 20266:17 PM ET | ADAR1 Capital Management, LLCand 2 others | 13G/A | 9.90%1.65M shares | 0.00 ppfrom 9.90% | Dec 31, 2025 | SEC |
| Feb 13, 20265:00 PM ET | Nantahala Capital Management, LLCand 2 others | 13G/A | 9.99%1.59M shares | 0.00 ppfrom 9.99% | Dec 31, 2025 | SEC |
| Jan 28, 20262:24 PM ET | Hirschman Orinand 1 other | 13G/A | 5.90%907.2K shares | −4.00 ppfrom 9.90% | Dec 31, 2025 | SEC |
| Nov 14, 20257:44 PM ET | ADAR1 Capital Management, LLCand 2 others | 13G/A | 9.90%1.53M shares | −0.09 ppfrom 9.99% | Sep 30, 2025 | SEC |
| Aug 14, 20254:43 PM ET | Nantahala Capital Management, LLCand 2 others | 13G/A | 9.99%1.40M shares | 0.00 ppfrom 9.99% | Jun 30, 2025 | SEC |
| May 15, 20257:33 PM ET | ADAR1 Capital Management, LLCand 2 others | 13G/A | 9.99%1.50M shares | – | Mar 31, 2025 | SEC |
| May 15, 20254:46 PM ET | Nantahala Capital Management, LLCand 2 others | 13G | 9.99%1.39M shares | New | Mar 31, 2025 | SEC |
| May 8, 20257:51 AM ET | Hirschman Orinand 1 other | 13G/A | 9.90%1.32M shares | +4.80 ppfrom 5.10% | Mar 31, 2025 | SEC |
| Jan 29, 20256:13 AM ET | Hirschman Orinand 1 other | 13G/A | 5.10%521.1K shares | – | Dec 31, 2024 | SEC |
| Nov 14, 2024 | ADAR1 Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Bank of America Corp | 13G/AOld format | – | – | – | SEC |
| Jul 10, 2024 | ADAR1 Capital Management, LLC | 13GOld format | – | New | – | SEC |
| Apr 9, 2024 | Hirschman Orin | 13GOld format | – | New | – | SEC |
| Feb 13, 2024 | Bank of America Corp | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Grace Therapeutics, Inc. shares.
No Form 144 notices for Grace Therapeutics, Inc. are on file.